The latest research from Fore Pharma, Global Psoriasis Clinical Trial Pipeline Highlights – 2021, provides most up-to-date information on key pipeline products in the global Psoriasis market. It covers emerging therapies for Psoriasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this research helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
- Products by Clinical Trial Stages: Psoriasis pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
- Drug Mechanism Classes: Psoriasis pipeline products by their dominant mechanism of action / drug class. This helps executives categorize products based on their drug class.
- Company: Psoriasis pipeline products by developing company.
- Short-term Launch Highlights: Find out which Psoriasis pipeline products will be launched in the US and Ex-US till 2026.
Summary of Contents:
– Psoriasis phase 3 clinical trial pipeline products
– Psoriasis phase 2 clinical trial pipeline products
– Psoriasis phase 1 clinical trial pipeline products
– Psoriasis preclinical research pipeline products
– Psoriasis discovery stage pipeline products
– Psoriasis pipeline products short-term launch highlights
Table of Contents
1. Psoriasis Pipeline by Stages
2. Psoriasis Phase 3 Clinical Trial Insights
3. Psoriasis Phase 2 Clinical Trial Insights
4. Psoriasis Phase 1 Clinical Trial Insights
5. Psoriasis Preclinical Research Insights
6. Psoriasis Discovery Stage Insights
8. Research Methodology
List of Tables
Table 1: Psoriasis Phase 3 Clinical Trials, 2021
Table 2: Psoriasis Phase 2 Clinical Trials, 2021
Table 3: Psoriasis Phase 1 Clinical Trials, 2021
Table 4: Psoriasis Preclinical Research, 2021
Table 5: Psoriasis Discovery Stage, 2021
List of Figures
Figure 1: Psoriasis Pipeline Molecules by Clinical Trials Stage, 2021
Figure 2: Psoriasis Phase 3 Clinical Trial Highlights, 2021
Figure 3: Psoriasis Phase 2 Clinical Trial Highlights, 2021
Figure 4: Psoriasis Phase 1 Clinical Trial Highlights, 2021
Figure 5: Psoriasis Preclinical Research Highlights, 2021
Figure 6: Psoriasis Discovery Stage Highlights, 2021
Default dispatch format is PDF.